Detalles de la búsqueda
1.
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium.
J Urol
; 209(4): 701-709, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36573926
2.
Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol
; 2024 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38290965
3.
Prognostic Models in Metastatic Renal Cell Carcinoma.
Hematol Oncol Clin North Am
; 37(5): 925-935, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37270385
4.
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma.
Eur Urol
; 84(1): 109-116, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36707357
5.
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol Oncol
; 2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914579
6.
TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report.
Curr Oncol
; 29(6): 3933-3939, 2022 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35735423
7.
Reply to Binghao Zhao, Hao Xing, and Wenbin Ma's Letter to the Editor re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116.
Eur Urol
; 84(1): e18-e19, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37080894
8.
Corrigendum to "Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma" [Eur Urol 2023].
Eur Urol
; 83(6): e166-e167, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36967358
Resultados
1 -
8
de 8
1
Próxima >
>>